Loyal | Strategic Alliance Partners

Loyal is a veterinary biotech company based in SF. Our mission is to develop the first drugs specifically designed to extend healthspan and lifespan. Loyal prides itself on being vet-focused, and partners closely with veterinarians to conduct clinical trials.

Blog

For Veterinarians

Connect with us:

Latest from Loyal

The Senior Dog Veterinary Society forges partnerships to improve patient care

Kristen Coppock Crossley, MA

March 26th 2025

Longevity drug developer Loyal and pain therapy manufacturer Elanco Animal Health are working with the organization to promote the need for aging canine care and enhance veterinary resources.

Second drug for canine healthy lifespan extension receives FDA support

Kristen Coppock Crossley, MA

February 26th 2025

Loyal’s developmental therapy aims to increase longevity and quality of life for senior dogs

Using lab values to identify disease that leads to aging

Kristen Coppock, MA, Associate Editorial Director

September 28th 2024

Brennen McKenzie, VMD, MSc, MA, director of veterinary medicine at Loyal, a biotechnology company, and a clinical practitioner, discusses the use of lab values as predictors for disease.

Watch

Understanding how metabolic dysfunction affects canine aging

Kristen Coppock, MA, Associate Editorial Director

September 27th 2024

Brennen McKenzie, VMD, MSc, MA, discusses how metabolic dysfunction impairs health in older dogs, in a dvm360 interview.

Watch

Loyal appoints Blake Scholl to its board of directors

dvm360 Staff

February 16th 2023

Scholl brings extensive entrepreneurial experience and technical innovation to help Loyal deliver world’s first FDA-approved longevity drug